Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived PeptidesReport as inadecuate




Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived Peptides - Download this document for free, or read online. Document in PDF available to download.

Animal models with defective glucagon action show hyperplasia of islet α-cells, however, the regulatory mechanisms underlying the proliferation of islet endocrine cells remain largely to be elucidated. The Gcggfp-gfp mice, which are homozygous for glucagon-green fluorescent protein knock-in allele GCGKO, lack all proglucagon-derived peptides including glucagon and GLP-1. The present study was aimed to characterize pancreatic neuroendocrine tumors panNETs, which develop in the GCGKO mice. At 15 months of age, macroscopic GFP-positive tumors were identified in the pancreas of all the GCGKO mice, but not in that of the control heterozygous mice. The tumor manifested several features that were consistent with pancreatic neuroendocrine tumors panNETs, such as organoid structures with trabecular and cribriform patterns, and the expression of chromogranin A and synaptophysin. Dissemination of GFP-positive cells was observed in the liver and lungs in 100% and 95%, respectively, of 15-month-old GCGKO mice. To elucidate the regulatory mechanism for tumor growth, PanNET grafts were transplanted into subrenal capsules in GCGKO and control mice. Ki-67 positive cells were identified in panNET grafts transplanted to GCGKO mice 1 month after transplantation, but not in those to control mice. These results suggest that humoral factors or conditions specific to GCGKO mice, are involved in the proliferation of panNETs. Taken together, GCGKO mice are novel animal model for studying the development, pathogenesis, and metastasis panNETs.



Author: Yuko Takano, Kenji Kasai, Yoshiko Takagishi, Toyone Kikumori, Tsuneo Imai, Yoshiharu Murata, Yoshitaka Hayashi

Source: http://plos.srce.hr/



DOWNLOAD PDF




Related documents